三葉草生物-B(02197.HK)稱其新冠疫苗年峰值產能料可達數億劑

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

三葉草生物-B(02197.HK)稱其新冠疫苗年峰值產能料可達數億劑

阿思達克 12-15 14:44

內媒報道，三葉草生物-B(02197.HK)回應新冠病毒疫苗的生產情況，指其生產的重組新冠病毒蛋白亞單位疫苗(CHO細胞)的年峰值產能預計可達數億劑。公司表示，將積極配合相關政府部門，為重點人群的第二劑次加強免疫接種提供支持。三葉草生物今日(15日)股價下挫，現跌6.86%，成交4,534.55萬股，涉資1.52億元。(ek/k) ~

三葉草生物-B(02197.HK)

Relevant Stocks

三葉草生物-B(02197.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

三葉草生物-B(02197.HK)稱其新冠疫苗年峰值產能料可達數億劑

Services

About Us

Agreement Statement